Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Kidney Function in Advanced Chronic Kidney Disease

NCT06982079 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Disease Stage 5
CKD Stage 4

Interventions

DRUG: Dapagliflozin 10 mg

Sponsor

Ain Shams University